Christina H. Ruhlmann/sdu.dk
Jan 11, 2025, 08:42
Christina H. Ruhlmann: Assessing the current management of immune-related adverse events
Christina H. Ruhlmann, Associate Professor at OUH Odense University Hospital, shared a post on LinkedIn:
”Calling my Immune-Oncology Network in Europe.
A project under the auspices of the ESMO Faculty of Supportive and Palliative Care and the Practicing Oncology Working Group aims to assess the current management of immune-related adverse events (irAEs). The results will inform us about the differential needs for improving management strategies impacting a continuously growing number of cancer patients receiving immune checkpoint inhibitors.
On behalf of the incredible European IO-tox Group, I invite you to take this short survey – thank you!
Use the following link if the QR code fails.”
More posts featuring Christina H. Ruhlmann.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26